NELSON LABS
Board
3 directors, 1 in day-to-day management, 1 auditor, last change in July 2026Schrawder Joseph A
Director
since 01-01-2021
term until 03-05-2027
listed in the 2025 annual accounts, filed on 27-07-2026
GARA BV
Director and managing director, permanent representative Kurt Marcel Ursula PEETERS
director since 30-11-2024
managing director appointed by deed of 24-02-2025
term without a fixed end
listed in the 2025 annual accounts, filed on 27-07-2026
Statutory auditor, permanent representative HEMSCHOOTE Piet
current term since 15-09-2023
3-year term from 2023
listed in the 2025 annual accounts, filed on 27-07-2026
- GARA
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “Artikel 12. Externe vertegenwoordiging De vennootschap wordt jegens derden en in rechte als eiser of als verweerder tevens geldig…”deed of 10-08-2026
Permanent representatives 1
Mandates through the years
12 names, the dashed line is todaySchrawder Joseph A
Director
Director
GARA
Director, Managing director
Director, Managing director
Riaz Amirali BANDALI
Director
Director
Ernst et Young Reviseurs d'Entreprises
Statutory auditor
Statutory auditor
Joseph A. Shrawder
Director
Director
Eric Meyers
Managing director
Managing director
Bruce T. Krarup
Director
Director
BOLLEN Jos
Director
Director
Joseph Bollen
Director
Director
Jeff Nelson
Director
Director
Petras Michael
Director
Director
Scott Leffler
Director
Director
LeadershipBoardEarlierRest of the termmandate already running before its first mentionend not dated
Mandates as a list
- Schrawder Joseph A
- Director, from 01-01-2021 to date
- GARA
- Director, from 30-11-2024 to date
- Managing director, appointed by deed of 24-02-2025, still in office
- Riaz Amirali BANDALI
- Director, appointed by deed of 04-08-2026, still in office
- Ernst et Young Reviseurs d'Entreprises
- Statutory auditor, from 21-04-2021 to date
- Joseph A. Shrawder
- Director, appointed by deed of 18-03-2021, until 30-06-2026
- Eric Meyers
- Director, appointed by deed of 18-03-2021, until 30-11-2024
- Managing director, appointed by deed of 26-04-2021, until 30-11-2024
- Bruce T. Krarup
- Director, appointed by deed of 18-03-2021, until 03-03-2023
- BOLLEN Jos
- Managing director, until 31-12-2020
- Managing director, until 18-03-2021
- Director, appointed by deed of 02-09-2021, no longer listed in the 2025 annual accounts
- Joseph Bollen
- Director, until 30-06-2021
- Jeff Nelson
- Director, until 18-03-2021
- Petras Michael
- Director, until 18-03-2021
- Scott Leffler
- Director, until 18-03-2021
Control
99.58%
This company
NELSON LABS
Equity €595.3m
Profit €38.1m in 2025
Further up the chainSotera Health Holdings LLC US 100%
Capital
- Contribution
- €347,500
- Shares
- 278
- Contribution per share
- €1,250
- Equity per share
- €2,141,436 in 2025
- Source
- 2025 annual accounts
Owners through the years
as the annual accounts name themOwners as a list
- STERIGENICS
- STERIGENICS BELGIUM (Petit Rechain)
- Sotera Health Holdings LLC
- GTCR
- Sotera Health LLC
- Toxikon
Source: shareholder structure in its own accounts, parent in its own accounts, lists of holdings in the owners' accounts
Articles of association
- Name, seat, purpose and duration
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 10-08-2026 (in Dutch)
- Board and representation
- Daily managementDay-to-day management handles the everyday running of the business without the full board.
- The board decides whether the delegates act alone or jointlydeed of 10-08-2026 (in Dutch)
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- “Alle handelingen die nodig of dienstig zijn tot verwezenlijking van het voorwerp, gewone meerderheid van de stemmen van de aanwezige of…”deed of 10-08-2026 (in Dutch)
- Power of attorneyA power of attorney lets someone perform specific acts on the company's behalf.
- “Susana Gonzalez Melon”“Hannelore De Bie”“Dries Remeysen”deed of 04-08-2026 (in Dutch)
- General meeting and financial year
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Monday of May at 14:00deed of 10-08-2026 (in Dutch)
- Audit, dissolution and liquidation
- Dissolution ruleThe articles set when and by whom the company can be dissolved.
- “Bij wet bepaalde gevallen, besluit algemene vergadering beraadslagend op wijze door wet vereist”deed of 02-09-2021 (in Dutch)
- Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
- “Alle machten genoemd in artikel 2:87 Wetboek van vennootschappen en verenigingen zonder bijzondere machtiging, algemene vergadering kan ten…”deed of 02-09-2021 (in Dutch)
Shareholders
2 ownersOwners 2
- STERIGENICSparentEquity €469.5m Profit of €93.9m in 2025 (profit of €375.8m in 2024) Checked score 9599.58%
- Equity €64.9m Profit of €15.3m in 2025 (profit of €13.9m in 2024) Checked score 96Sourceown accounts 20250.41%
Capital transactions
Capital over time
- 10-08-2026 Converted to available equity
- 13-12-2024 Capital increase of €108,911,597.93 · 37 new shares at €2,943,556.70 per share
- 13-11-2024 Capital increase of €404,839,944.73 · 141 new shares at €2,870,644.66 per share
- 02-09-2021 Capital stated in the deed · €125,000 · 100 shares